Steroid Treatment Focused Management of Graves’ Ophthalmopathy
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H. +5 more
doaj +1 more source
Update on the medical treatment of Graves’ ophthalmopathy
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj
Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]
Yeung A +9 more
europepmc +1 more source
Correction: Extraocular muscle index as a novel indicator of inflammatory condition in graves' ophthalmopathy patients. [PDF]
Wu F +5 more
europepmc +1 more source
Euthyroid Graves' Ophthalmopathy With Negative Antibodies (EGONA): A Comprehensive Case-Based Review. [PDF]
Bonny M +6 more
europepmc +1 more source
New-Onset Graves' Ophthalmopathy After Treatment with Pembrolizumab: A Case Report and a Review of the Literature. [PDF]
Pan M, Zhou X, Wu Y.
europepmc +1 more source
Clinical value of dual-energy CT parameters combined with morphological features in predicting graves' ophthalmopathy. [PDF]
Ma Z +7 more
europepmc +1 more source
Emerging therapeutic approaches in graves' ophthalmopathy: an update on pharmacological interventions. [PDF]
Wang L, Chen L.
europepmc +1 more source
Effect of orbital fat decompression on eyelid contour according to midpupil lid distance in graves' ophthalmopathy. [PDF]
Wang YW, Huang WL, Liao SL, Wei YH.
europepmc +1 more source

